Molecule Structure

Scientific Name

Naloxone

Description of the Drug

Naloxone is an opioid receptor antagonist used to rapidly reverse an opioid overdose. Also included in some drug formulations as an abuse deterrent to prevent injection.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01183

Brand Name(s)

Nalone, Narcan, Narcanti

Company Owner(s)

Igi Laboratories Inc, Alkem Laboratories Ltd, Solopak Medical Products Inc, Watson Laboratories Inc, Dr Reddys Laboratories Sa, Rhodes Pharmaceuticals Lp, Amneal Pharmaceuticals Of New York Llc, Wes Pharma Inc, Akorn Operating Co Llc, Hikma Pharmaceuticals International Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Opioid receptors; mu/kappa/delta PROTEIN FAMILY ANTAGONIST CHEMBL2095181

Unichem Links

SureChEMBL SCHEMBL34284
PharmGKB PA450586
Human Metabolome Database HMDB0015314
DrugBank DB01183
PubChem: Thomson Pharma 16463984 14777335 14924176
PubChem 5284596
Mcule MCULE-1335589007
NMRShiftDB 60067801
LINCS LSM-3504
Nikkaji J5.894G
BindingDB 50000788 54795
EPA CompTox Dashboard DTXSID8023349
DrugCentral 1878
Metabolights MTBLC7459
Brenda 6568 36382
ChemicalBook CB5728727
Guide to Pharmacology 1638 1676
rxnorm NALOXONE HYDROCHLORIDE NALOXONE NARCAN EVZIO SUBOXONE
KEGG Ligand C07252
ChEBI 7459
ZINC ZINC000000389747